A low molecular weight fraction of serum from uremic patients has been found to inhibit several different transport systems. These include the uptake of p-aminohippuric acid (PAH) by rabbit kidney cortical slices, the transepithelial transport of sodium by the isolated frog skin, and finally, sodium reabsorption by the rat kidney tubule. The following possibilities are considered: first, that the substance might be a naturally occurring humoral agent which serves in a homeostatic role to increase sodium excretion rate per nephron as the number of nephrons diminishes in advancing renal disease; and second, that in advanced renal disease, very high levels of this humoral agent could lead to inhibition of sodium transport in extrarenal organs and, thus, could contribute importantly to the symptoms and signs of the uremic state.
Bricker NS, Bourgoignie JJ, Klahr S. A Humoral Inhibitor of Sodium Transport in Uremic Serum: A Potential Toxin? Arch Intern Med. 1970;126(5):860–864. doi:10.1001/archinte.1970.00310110130023
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: